Exploring the molecular basis of antifungal synergies using genome-wide approaches

Frontiers in Microbiology

Volumn 3, Issue MAR, 2012, Pages

  Agarwal, Ameeta K ^a   Tripathi, Siddharth K ^a   Xu, Tao ^a,c   Jacob, Melissa R ^a   Li, Xing Cong ^a   Clark, Alice M ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Chemogenomic profiling; Drug synergy mechanism; Genetic interaction

Indexed keywords

EID: 84874629282     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00115     Document Type: Article

References (38)

1. Agarwal, A. K., Xu, T., Jacob, M. R., Feng, Q., Li, X. C., Walker, L. A., and Clark, A. M. (2008). Genomic and genetic approaches for the identification of antifungal drug targets. Infect. Disord. DrugTargets 8, 2-15.
2. Ahmad, A., Khan, A., Khan, L. A., and Manzoor, N. (2010). In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates. J. Med. Microbiol. 59, 1178-1184.
3. Baryshnikova, A., Costanzo, M., Kim, Y., Ding, H., Koh, J., Toufighi, K., Youn, J. Y., Ou, J., San Luis, B. J., Bandyopadhyay, S., Hibbs, M., Hess, D., Gingras, A. C., Bader, G. D., Troyanskaya, O. G., Brown, G. W., Andrews, B., Boone, C., and Myers, C. L. (2010). Quantitative analysis of fitness and genetic interactions in yeast on a genome scale. Nat. Methods7, 1017-1024.
4. Cokol, M., Chua, H. N., Tasan, M., Mutlu, B., Weinstein, Z. B., Suzuki, Y., Nergiz, M. E., Costanzo, M., Baryshnikova, A., Giaever, G., Nislow, C., Myers, C. L., Andrews, B. J., Boone, C., and Roth, E P. (2011). Systematic exploration of synergistic drug pairs. Mol Syst. Biol. 7, 544.
5. Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L., Toufighi, K., Mostafavi, S., Prinz, J., St Onge, R. P., Vandersluis, B., Makhnevych, T., Vizeacoumar, F. J., Alizadeh, S., Bahr, S., Brost, R. L., Chen, Y., Cokol, M., Deshpande, R., Li, Z., Lin, Z. Y., Liang, W., Marback, M., Paw, J., San Luis, B. J., Shuteriqi, E., Tong, A. H., Van Dyk, N., Wallace, I. M., Whitney, J. A., Weirauch, M. T., Zhong, G., Zhu, H., Houry, W. A., Brudno, M., Ragibizadeh, S., Papp, B., Pál, C., Roth, F. P., Giaever, G., Nislow, C., Troyanskaya, O. G., Bussey, H., Bader, G. D., Gingras, A. C., Morris, Q. D., Kim, P. M., Kaiser, C. A., Myers, C. L., Andrews, B. J., and Boone, C. (2010). The genetic landscape of acell. Science 327,425-431.
6. Denning, D. W., and Hope, W W. (2010). Therapy for fungal diseases: opportunities and priorities. Trends Microbiol. 18, 195-204.
7. Digirolamo, J. A., Li, X. C., Jacob, M. R., Clark, A. M., and Ferreira, D. (2009). Reversal of fluconazole resistance by sulfated sterols from the marine sponge Topsentia sp. J. Nat. Prod. 72, 1524-1528.
8. Gamarra, S., Rocha, E. M., Zhang, Y Q., Park, S., Rao, R., and Per-lin, D. S. (2010). Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans. Antimicrob. Agents Chemother. 54, 1753-1761.
9. Ho, C. H., Piotrowski, J., Dixon, S. J., Baryshnikova, A., Costanzo, M., and Boone, C. (2011). Combining functional genomics and chemical biology to identify targets of bioactive compounds. Curr. Opin. Chem. Biol. 15, 66-78.
10. Hoon, S., Smith, A. M., Wallace, I. M., Suresh, S., Miranda, M., Fung, E., Proctor, M., Shokat, K. M., Zhang, C., Davis, R. W., Giaever, G., St Onge, R. P., and Nislow, C. (2008a). An integrated platform of genomic assays reveals small-molecule bioactivities. Nat. Chem. Biol. 4, 498-506.
11. Hoon, S., St Onge, R. P., Giaever, G., and Nislow, C. (2008b). Yeast chemical genomics and drug discovery: an update. Trends Pharmacol Sci. 29, 499-504.
12. Jacob, M. R., Hossain, C. F., Mohammed, K. A., Smillie, T. J., Clark, A. M., Walker, L. A., and Nagle, D. G. (2003). Reversal of fluconazole resistance in multidrug efflux-resistant fungi by the Dysidea arenaria sponge sterol 9α,11α-epoxycholest-7-ene-3β,5α,6α,19-tetrol 6-acetate. J. Nat. Prod. 66, 1618-1622.
13. Jansen, G., Lee, A. Y., Epp, E., Fredette, A., Surprenant, J., Harcus, D., Scott, M., Tan, E., Nishimura, T., White-way, M., Hallett, M., and Thomas, D. Y (2009). Chemogenomic profiling predicts antifungal synergies. Mol Syst. Biol. 5, 338.
14. Jia, J., Zhu, F., Ma, X., Cao, Z., Li, Y., and Chen, Y Z. (2009). Mechanisms of drug combinations: interaction and network perspectives. Nat. Rev. Drug Discov.8, 111-128.
15. Johnson, M. D., Macdougall, C., Ostrosky-Zeichner, L., Perfect, J. R., and Rex, J. H. (2004). Combination antifungal therapy. Antimicrob. Agents Chemother. 48, 693-715.
16. Lehár, J., Zimmermann, G. R., Krueger, A. S., Molnar, R. A., Ledell, J. T., Heilbut, A. M., Short, G. F. III, Giusti, L. C., Nolan, G. P., Magi d, O. A., Lee, M. S., Borisy, A. A., Stockwell, B. R., and Keith, C. T. (2007). Chemical combination effects predict connectivity in biological systems. Mol Syst. Biol. 3,80.
17. Li, X. C., Jacob, M. R., Ding, Y., Agarwal, A. K., Smillie, T. J., Khan, S. I., Nagle, D. G., Ferreira, D., and Clark, A. M. (2006). Capisterones A and B, which enhance fluconazole activity in Saccharomyces cerevisiae, from the marine green alga Penicillus capitatus. J. Nat. Prod. 69, 542-546.
18. Li, Y., Hong, X., Hussain, M., Sarkar, S. H., Li, R., and Sarkar, F. H. (2005). Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells. Mol Cancer Ther. 4, 389-398.
19. Maertens, J. A. (2004). History of the development of azole derivatives. Clin. Microbiol Infect. 10(Suppl. 1), 1-10.
20. Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A., and Ghannoum, M. A. (2005). Combination treatment of invasive fungal infections. Clin. Microbiol Rev. 18, 163-194.
21. Mukherjee, P. K., and Wang, M. (2010). "Antifungal drug resistance: significance and mechanisms," in Antifungal Therapy, eds M. A. Ghannoum and J. R. Perfect (New York: Informa Healthcare), 63-86.
22. Niimi, K., Harding, D. R., Parshot, R., King, A., Lun, D. J., Decottig-nies, A., Niimi, M., Lin, S., Cannon, R. D., Goffeau, A., and Monk, B. C. (2004). Chemosensitization of fluconazole resistance in Saccha romyces cerevisiae and pathogenic fungi by a D-octapeptide derivative. Antimicrob. Agents Chemother. 48, 1256-1271.
23. Onyewu, C., Blankenship, J. R., Del Poeta, M., and Heitman, J. (2003). Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob. Agents Chemother. 47, 956-964.
24. Parsons, A. B., Lopez, A., Givoni, I. E., Williams, D. E., Gray, C. A., Porter, J., Chua, G., Sopko, R., Brost, R. L., Ho, C. H., Wang, J., Ketela, T., Brenner, C., Brill, J. A., Fernandez, G. E., Lorenz, T. C., Payne, G. S., Ishihara, S., Ohya, Y., Andrews, B., Hughes, T. R., Frey, B. J., Graham, T. R., Andersen, R. J., and Boone, C. (2006). Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126,611-625.
25. Pasqualotto, A. C., and Denning, D. W. (2008). New and emerging treatments for fungal infections. J. Antimicrob. Chemother. 61(Suppl. 1),i19-i30.
26. Pemán, J., Cantón, E., and Espinel-Ingroff, A. (2009). Antifungal drug resistance mechanisms. Expert Rev. Anti. Infect. Ther. 7, 453-460.
27. Perlin, D. S. (2007). Resistance to echinocandin-class antifungal drugs. Drug Resist. Updat. 10, 121-130.
28. Petrikkos, G., and Skiada, A. (2007). Recent advances in antifungal chemotherapy. Int. J. Antimicrob. Agents 30, 108-117.
29. Pfaller, M. A., Messer, S. A., Geor-gopapadakou, N., Martell, L. A., Besterman, J. M., and Diekema, D. J. (2009). Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole anti-fungals against opportunistic fungal pathogens. J. Clin. Microbiol. 47, 3797-3804.
30. Sanglard, D. (2002). Resistance of human fungal pathogens to antifungal drugs. Curr. Opin. Microbiol. 5, 379-385.
31. Sharma, M., Manoharlal, R., Negi, A. S., and Prasad, R. (2010). Syner-gistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis. FEMS Yeast Res. 10, 570-578.
32. Spitzer, M., Griffiths, E., Blakely, K. M., Wildenhain, J., Ejim, L., Rossi, L., De Pascale, G., Curak, J., Brown, E., Tyers, M., and Wright, G. D. (2011). Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole. Mol Syst. Biol. 7, 499.
33. Tiziani, S., Lodi, A., Khanim, F. L., Viant, M. R., Bunce, C. M., and Günther, U. L. (2009). Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines. PLoS ONE 4, e4251. doi:10.1371/jour-nal.pone.0004251
34. Tong, A. H., Lesage, G., Bader, G. D., Ding, H., Xu, H., Xin, X., Young, J., Berriz, G. F., Brost, R. L., Chang, M., Chen, Y., Cheng, X., Chua, G., Friesen, H., Goldberg, D. S., Haynes, J., Humphries, C., He, G., Hussein, S., Ke, L., Krogan, N., Li, Z., Levin-son, J. N., Lu, H., Menard, P., Mun-yana, C., Parsons, A. B., Ryan, O., Tonikian, R., Roberts, T., Sdicu, A. M., Shapiro, J., Sheikh, B., Suter, B., Wong, S. L., Zhang, L. V., Zhu, H., Burd, C. G., Munro, S., Sander, C., Rine, J., Greenblatt, J., Peter, M., Bretscher, A., Bell, G., Roth, E P., Brown, G. W., Andrews, B., Bussey, H., and Boone, C. (2004). Global mapping of the yeast genetic interaction network. Science 303, 808-813.
35. Wei, G. X., Xu, X., and Wu, C. D. (2011). In vitro synergism between berber-ine and miconazole against plank-tonic and biofilm Candida cultures. Arch. Oral Biol. 56, 565-572.
36. Xu, Y., Wang, Y., Yan, L., Liang, R. M., Dai, B. D., Tang, R. J., Gao, P. H., and Jiang, Y Y (2009). Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation. J. Proteome Res. 8, 5296-5304.
37. Yeh, P. J., Hegreness, M. J., Aiden, A. P., and Kishony, R. (2009). Drug interactions and the evolution of antibiotic resistance. Nat. Rev. Microbiol. 7, 460-466.
38. Zimmermann, G. R., Lehár, J., and Keith, C. T. (2007). Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov. Today 12, 34-42.